BlogTalkRadio uses cookies. By using our services, you're agreeing to our Cookies Policy. Got it

Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

"A Survivor's Story"

  • Broadcast in Women
WOW Inspiration

WOW Inspiration


Follow This Show

If you liked this show, you should follow WOW Inspiration.

Join us  Thursday October 2, 2014 at 5:30 pm to hear  a triumphant story of Breast cancer Survival from Mrs. Cassandra Levine.

Check out these facts:

Breast cancer is the most commonly diagnosed cancer among African American women. An estimated 27,060 new cases of breast cancer are expected to occur among African American women in 2013. Among younger women (under age 45), however, the mortality rate of breast cancer is higher in African Americans than in whites. The median age of diagnosis is 57 years for African American women, compared to 62 years for white women. Breast cancer incidence rates increased rapidly among African American women during the 1980s, largely due to increased detection as the use of mammography screening increased, then rates increased more gradually during the 1990s 6. In the most recent time period (2000-2009), breast cancer incidence rates increased slightly among African American women (0.7% per year) and decreased among white women (1.0% per year). The decrease in white women during this time period in part reflects the sharp decline between 2002 and 2003 that was related to a drop in use of menopausal hormones. 27 A similar drop in incidence was not observed in African American women among whom menopausal hormone use is historically lower.
Breast cancers diagnosed in African American women are more likely to have factors associated with poor prognosis, such as higher grade, advanced stage, and negative hormone (estrogen [ER] and progesterone [PR]) receptor status, than those diagnosed in white women. 30 – 32 Furthermore, premenopausal African American women in particular appear to have a higher risk for triple-negative (ER negative, PR negative, and  human epidermal growth factor receptor [HER] 2 negative) and basal-like breast cancers, which are distinct but overlapping aggressive subtypes of breast cancer that are associated with shorter life.